Regan Zambri Long PLLC
English Español
Call Now 202-960-4596
Menu
06/22/10   |   By

FDA Warning: Counterfeit Tamiflu | DC Metro Area Medical Malpractice Law Blog

5 stars

The Food and Drug Administration (FDA) has released a report about the sale of Generic Tamiflu over the internet. Tamiflu, a drug used for the treatment of patients with illness due to influenza that contains the active ingredient oseltamivir, has been sold through websites claiming to be online drug stores.  The Generic Tamiflu that is being sold through these websites has cloxacillin as its active ingredient, which belongs to the same class of antibiotics as penicillin.  Patients who are allergic to penicillin will possibly see a similar life-threatening anaphylactic reaction to cloxacillin, including the following symptoms:

  • Labored/Difficult breathing
  • Chest tightness
  • Swelling of the throat/tongue
  • Dizziness
  • Hives
  • Loss of consciousness
  • Rapid or weak pulse

The FDA advises patients that possess or come across the counterfeit Tamiflu to discontinue use and contact the FDA’s Office of Criminal Investigations.

A list of legitimate pharmacies that carry a seal from the Verified Internet Pharmacy Practice Sites (VIPPS) can be found here.

The original FDA safety advisory can be found here.

Regan Zambri Long
Posted In
Uncategorized
Share This Article

Archives

Schedule a Free Consultation

Have you or your loved one sustained injuries in Washington DC, Maryland or Virginia? Regan Zambri Long PLLC has the best lawyers in the country to analyze your case and answer the questions you may have.

Call 202-960-4596

  • Please do not send any confidential or sensitive information in this form. This form sends information by non-encrypted email, which is not secure. Submitting this form does not create an attorney-client relationship.

  • This field is for validation purposes and should be left unchanged.
Back to Top